Copyright ©ERS Journals Ltd 2008 Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells1 Dept of Paediatrics, Faculty of Paediatrics, College of Medicine, 2 Dept of Paediatrics, Kaohsiung Medical University Hospital, and 3 Graduate Institute of Medicine, Kaohsiung Medical University, and 4 Dept of Paediatrics, Tri-Service General Hospital, Kaohsiung, Taiwan, Republic of China. CORRESPONDENCE: Y-J. Jong, Dept of Paediatrics, Kaohsiung Medical University Hospital, No. 100, Tz-You 1st Road, Kaohsiung 807, Taiwan, Republic of China. Fax: 886 73213931. E-mail: pedhung{at}kmu.edu.tw Keywords: β2-Adrenoreceptor agonist, bronchial epithelial cells, bronchodilators, CC chemokines, macrophage, monocyte
Received: September 15, 2006
It is unknown whether formoterol and salmeterol, two long-acting β2-adrenoreceptor agonists, have regulatory functions in the production of T-helper cell (Th) type 2- and Th1-related chemokines by monocytes and bronchial epithelial cells.
In the present study, the effects of formoterol and salmeterol on lipopolysaccharide (LPS)-induced expression of the Th2-related chemokine macrophage-derived chemokine (MDC; CCL22) and the Th1-related chemokine interferon-
Formoterol enhanced MDC but suppressed IP-10 production in monocytes induced by LPS. Higher doses of salmeterol were required to enhance LPS-induced MDC expression in THP-1 cells. Formoterol and salmeterol could significantly suppress TARC expression in BEAS-2B cells. These effects could be reversed by a selective β2-adrenoreceptor antagonist, ICI-118551. Formoterol- and LPS-induced MDC expression was inhibited by budesonide.
Both long-acting β2-adrenoreceptor agonists suppressed thymus- and activation-regulated chemokine expression in bronchial epithelial cells mediated via β2-adrenoreceptors. Formoterol at physiological concentrations could suppress lipopolysaccharide-induced T-helper cell type 1-related chemokine (interferon-
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||